Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

计划入组 105 人 · 首次发布于 2003 年 2 月 6 日

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

计划入组 40 人 · 首次发布于 2012 年 10 月 4 日

Brentuximab Vedotin for Steroid Refractory GvHD

计划入组 35 人 · 首次发布于 2012 年 5 月 10 日

Graft vs. Host Disease(Aegle)

Graft-versus-host disease therapeutics (Mallinckrodt)

Graft-versus-host disease therapy(Applied StemCell, Inc.)

Vascular Graft Solutions Ltd.

Israel

Rare Disease Research, LLC

Theriva Biologics

United States

FDA Accepts Resubmitted BLA for Remestemcel-L in Pediatric Steroid-Refractory Acute GVHD

Advances in Transplant Eligibility Expand Treatment Options for Secondary AML Patients

ReAlta Life Sciences Appoints Biotech Veteran Jonathan Rigby to Board as Company Advances Inflammation-Targeting Pipeline